The customer observed a falsely elevated architect afp result on a (b)(6) year-old female patient.The following data was provided: initial result, on (b)(6) 2020, was 11 ng/ml, a few days later, it was repeated at another hospital with a result of about 4 (unknown unit of measure).It is unknown on what platform the repeat result was generated.It is unknown if the patient is pregnant.There was no impact to patient management.
|
The complaint investigation for falsely elevated architect afp results included a search for similar complaints, review of complaint text, trending data, labeling, and device history records.Return testing was not completed as returns were not available.Using worldwide field data, the performance of reagent lot 08069fn00 and associated sublots manufactured with the same material were evaluated and are performing similar to other reagent lots in the field confirming there was no systemic issue.Trending review determined no adverse trend for the issue for the product.Device history record review on lot 08069fn00 did not show any potential non-conformances or deviations.Labeling was reviewed and found to adequately address the issue under review.All specifications were met indicating that the lot is performing acceptably.Based on the information provided and abbott diagnostics' complaint investigation, no systemic issue or deficiency of the architect afp assay, lot number 08069fn00, was identified.
|